Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Results from a meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 10, 2015, Pages 17221-17234

  Wang, Xiang ^a   Li, Weiping ^b   Zhang, Ying ^a   Yang, Yang ^a   Qin, Guijun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b The First Hospital of Yangquan City   (China)

Author keywords

Meta analysis; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D;

ARTICLE; BIBLIOGRAPHIC DATABASE; DISEASE ASSOCIATION; HUMAN; META ANALYSIS (TOPIC); NEWCASTLE OTTAWA SCALE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; RATING SCALE; SENSITIVITY ANALYSIS; VITAMIN BLOOD LEVEL;

EID: 84949667650     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Wieckowska A, McCullough AJ and Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 2007; 46: 582-589.
2. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterologyh. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609.
3. Ascha MS, Hanouneh IA, Lopez R, Tamimi TA, Feldstein AF and Zein NN. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010; 51: 1972-1978.
4. Bhala N, Angulo P, van der Poorten D, Lee E, Hui JM, Saracco G, Adams LA, Charatcharoenwitthaya P, Topping JH, Bugianesi E, Day CP and George J. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology 2011; 54: 1208-1216.
5. Wong VW, Wong GL, Choi PC, Chan AW, Li MK, Chan HY, Chim AM, Yu J, Sung JJ and Chan HL. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010; 59: 969-974.
6. Mendez-Sanchez N, Arrese M, Zamora-Valdes D and Uribe M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 2007; 27: 423-433.
7. Kwok RM, Torres DM and Harrison SA. Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association? Hepatology 2013; 58: 1166-1174.
8. Ponchon G, Kennan AL and DeLuca HF. “Activation” of vitamin D by the liver. J Clin Invest 1969; 48: 2032-2037.
9. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
10. Chiu KC, Chu A, Go VL and Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
11. Forman JP, Curhan GC and Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008; 52: 828-832.
12. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y and Lin X. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32: 1278-1283.
13. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D’Agostino RB, Wolf M and Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-511.
14. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G and Arcaro G. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2007; 17: 517-524.
15. Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J and Chonchol M. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 2013; 23: 792-798.
16. Yildiz I, Erol OB, Toprak S, Cantez MS, Omer B, Kilic A, Oguz F, Uysalol M, Yekeler E and Unuvar E. Role of vitamin D in children with hepatosteatosis. J Pediatr Gastroenterol Nutr 2014; 59: 106-111.
17. Li L, Zhang L, Pan S, Wu X and Yin X. No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population. Dig Dis Sci 2013; 58: 2376-2382.
18. Cui R, Sheng H, Rui XF, Cheng XY, Sheng CJ, Wang JY and Qu S. Low bone mineral density in chinese adults with nonalcoholic Fatty liver disease. Int J Endocrinol 2013; 2013: 396545.
19. Higgins JP, Thompson SG, Deeks JJ and Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
20. Dasarathy J, Periyalwar P, Allampati S, Bhinder V, Hawkins C, Brandt P, Khiyami A, McCullough AJ and Dasarathy S. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int 2014; 34: e118-127.
21. Black LJ, Jacoby P, She Ping-Delfos WC, Mori TA, Beilin LJ, Olynyk JK, Ayonrinde OT, Huang RC, Holt PG, Hart PH, Oddy WH and Adams LA. Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity. J Gastroenterol Hepatol 2014; 29: 1215-1222.
22. Kucukazman M, Ata N, Dal KA, Yeniova AO, Kefeli AE, Basyigit S, Aktas B, Akin KO, K ALL, Ure OS, Topal F, Nazligul YA, Beyan E and Ertugrul DT. The association of vitamin D deficiency with non-alcoholic fatty liver disease. Clinics (Sao Paulo) 2014; 69: 542-546.
23. Hao YP, Ma XJ, Luo YQ, Ni J, Dou JX, Hu YQ, Zhu JA, Bao YQ and Jia WP. Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes. Acta Pharmacologica Sinica 2014; 35: 1150-1156.
24. Beilfuss A, Sowa JP, Sydor S, Beste M, Bechmann LP, Schlattjan M, Syn WK, Wedemeyer I, Mathe Z, Jochum C, Gerken G, Gieseler RK and Canbay A. Vitamin D counteracts fibrogenic TGF-(beta) signalling in human hepatic stellate cells both receptor-dependently and independently. Gut 2015; 64: 791-9.
25. Bril F, Maximos M, Portillo-Sanchez P, Biernacki D, Lomonaco R, Subbarayan S, Correa M, Lo M, Suman A and Cusi K. Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J Hepatol 2015; 62: 405-11.
26. Rhee EJ, Kim MK, Park SE, Park CY, Baek KH, Lee WY, Kang MI, Park SW, Kim SW and Oh KW. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J 2013; 60: 743-752.
27. Pirgon O, Cekmez F, Bilgin H, Eren E and Dundar B. Low 25-hydroxyvitamin D level is associated with insulin sensitivity in obese adolescents with non-alcoholic fatty liver disease. Obes Res Clin Pract 2013; 7: e275-283.
28. Kasapoglu B, Turkay C, Yalcin KS, Carlioglu A, Sozen M and Koktener A. Low vitamin D levels are associated with increased risk for fatty liver disease among non-obese adults. Clin Med 2013; 13: 576-579.
29. Bhatt SP, Nigam P, Misra A, Guleria R and Qadar Pasha MA. Independent associations of low 25 hydroxy vitamin D and high parathyroid hormonal levels with nonalcoholic fatty liver disease in Asian Indians residing in north India. Atherosclerosis 2013; 230: 157-163.
30. Catena C, Cosma C, Camozzi V, Plebani M, Ermani M, Sechi LA and Fallo F. Non-alcoholic fatty liver disease is not associated with vitamin D deficiency in essential hypertension. High Blood Pressure and Cardiovascular Prevention 2013; 20: 33-37.
31. Purnak T, Beyazit Y, Ozaslan E, Efe C and Hayretci M. The evaluation of bone mineral density in patients with nonalcoholic fatty liver disease. Wien Klin Wochenschr 2012; 124: 526-531.
32. Dasarathy J, Periyalwar P, Allampati S, Hawkins CA, Brandt PT, Khiyami A, McCullough AJ and Dasarathy S. Hypovitaminosis D associated with more advanced non alcoholic fatty liver disease. Hepatology 2012; 56: 889A-890A.
33. Barchetta I, Carotti S, Labbadia G, Gentilucci UV, Muda AO, Angelico F, Silecchia G, Leonetti F, Fraioli A, Picardi A, Morini S and Cavallo MG. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: Relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology 2012; 56: 2180-2187.
34. Barchetta I, Angelico F, Ben MD, Baroni MG, Pozzilli P, Morini S and Cavallo MG. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 2011; 9: 85.
35. Nseir W, Taha H, Khateeb J, Grosovski M and Assy N. Fatty liver is associated with recurrent bacterial infections independent of metabolic syndrome. Digest Dis Sci 2011; 56: 3328-3334.
36. Assy N, Abu-Mouch SM, Nseir W, Marmor A and Grozovski M. Association between 25-OH vitamin D concentrations and risk of coronary artery disease in patients with non alcoholic fatty liver disease. Hepatology 2010; 52: 632A.
37. Barchetta I, Cavallo MG, Angelico F, Ben MD, Fraioli A, Morini S and Pozzilli P. Hypovitaminosis D is associated with mild non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome’s components in dysmetabolic adult patients. Hepatology 2009; 50: 797A.
38. Malespin M, Sleesman B, Lau A, Wong SS and Cotler SJ. Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese American Children. J Clin Gastroenterol 2015; 49: 345-9.
39. Black L, Jacoby P, She Ping-Delfos W, Mori T, Beilin L, Olynyk J, Ayonrinde O, Huang R, Holt P, Hart P, Oddy W and Adams L. Low serum 25-hydroxyvitamin D concentrations are associated with non-alcoholic fatty liver disease in adolescents independent of adiposity. Obes Rev 2014; 15: 95.
40. Kim D, Kim W and Kim HJ. Serum vitamin D is inversely associated with nonalcoholic fatty liver disease and advanced fibrosis in the general population. Hepatology 2013; 58: 514A.
41. Seo JA, Eun CR, Cho H, Lee SK, Yoo HJ, Kim SG, Choi KM, Baik SH, Choi DS, Yim HJ, Shin C and Kim NH. Low Vitamin D Status Is Associated with Nonalcoholic Fatty Liver Disease Independent of Visceral Obesity in Korean Adults. PLoS One 2013; 8: e75179.
42. Foster T, Chalasani NP, Liangpunsakul S and Budoff M. The association of serum vitamin D concentrations and non alcoholic fatty liver disease (NAFLD): The multi ethnic study of atherosclerosis. Hepatology 2011; 54: 1129A-1130A.
43. Katz K, Brar PC, Parekh N, Liu YH and Weitzman M. Suspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. J Obes 2010; 2010: 496829.
44. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E and Clark JM. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891.
45. Pequeriaux NC, Fijnheer R, Gemen EF, Barendrecht AD, Dekker FW, Krediet RT, Beutler JJ, Boeschoten EW and Roest M. Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy. Nephrol Dial Transplant 2012; 27: 2452-2457.
46. Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, Huang YZ, Honda H, Chen KD, Wang CC, Chiu KW, Jawan B, Eng HL, Goto S and Chen CL. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2011; 55: 415-425.
47. Torres DM, Williams CD and Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012; 10: 837-858.
48. Abramovitch S, Dahan-Bachar L, Sharvit E, Weisman Y, Ben Tov A, Brazowski E and Reif S. Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats. Gut 2011; 60: 1728-1737.
49. Seydel S, Beilfuss A, Kahraman A, Aksoy K, Gerken G, Akkiz H and Canbay A. Vitamin D ameliorates stress ligand expression elicited by free fatty acids in the hepatic stellate cell line LX-2. Turk J Gastroenterol 2011; 22: 400-407.
50. Zuniga S, Firrincieli D, Housset C and Chignard N. Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol 2011; 35: 295-302.
51. Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, Kiel DP, Streeten EA, Ohlsson C, Koller DL, Peltonen L, Cooper JD, O’Reilly PF, Houston DK, Glazer NL, Vandenput L, Peacock M, Shi J, Rivadeneira F, McCarthy MI, Anneli P, de Boer IH, Mangino M, Kato B, Smyth DJ, Booth SL, Jacques PF, Burke GL, Goodarzi M, Cheung CL, Wolf M, Rice K, Goltzman D, Hidiroglou N, Ladouceur M, Wareham NJ, Hocking LJ, Hart D, Arden NK, Cooper C, Malik S, Fraser WD, Hartikainen AL, Zhai G, Macdonald HM, Forouhi NG, Loos RJ, Reid DM, Hakim A, Dennison E, Liu Y, Power C, Stevens HE, Jaana L, Vasan RS, Soranzo N, Bojunga J, Psaty BM, Lorentzon M, Foroud T, Harris TB, Hofman A, Jansson JO, Cauley JA, Uitterlinden AG, Gibson Q, Jarvelin MR, Karasik D, Siscovick DS, Econs MJ, Kritchevsky SB, Florez JC, Todd JA, Dupuis J, Hypponen E and Spector TD. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 2010; 376: 180-188.
52. Grunhage F, Hochrath K, Krawczyk M, Hoblinger A, Obermayer-Pietsch B, Geisel J, Trauner M, Sauerbruch T and Lammert F. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012; 56: 1883-1891.
53. Fan L, Tu X, Zhu Y, Zhou L, Pfeiffer T, Feltens R, Stoecker W and Zhong R. Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 2005; 20: 249-255.